Axcelis announces $200 million additional funding for share repurchase program

Beverly, mass. , sept. 12, 2023 /prnewswire/ -- axcelis technologies, inc. (nasdaq: acls), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced that its board of directors has authorized additional funding of $200 million for the company's share repurchase program.
ACLS Ratings Summary
ACLS Quant Ranking